A groundbreaking medication, administered in utero, offers new hope for treating spinal muscular atrophy (SMA). This innovative approach targets the condition before birth, potentially altering the trajectory of development and improving quality of life for affected infants.
Read MoreIn a significant step forward, the government has unveiled a new strategy to combat rare diseases, aiming to enhance research, improve patient care, and foster collaboration among healthcare providers. This initiative seeks to bring hope to those affected by these elusive conditions.
Read More